It’s time to address adult ADHD.
What does existing research say about the connection between substance use disorders and eating disorders?
Are investors harming mental health care?
Larry Miller, MD, CEO of Apnimed, discusses the ins and outs of sleep apnea.
Panelists discuss the clinical and practical advantages of pitolisant for patients with frequent cataplexy and concerns about controlled substances, highlighting its dual efficacy, favorable safety profile, and flexible dosing as key features that support a patient-centered, stigma-conscious approach to narcolepsy care.
Trauma-related psychiatric disorders such as PTSD and grief often go undetected and untreated in older adults. Here's how to help.
New research links reduced synaptic density,early psychosis, and cannabis use, offering insights into negative symptoms and potential interventions.
The FDA Meeting of the Psychopharmacologic Drugs Advisory Committee evaluating the New Drug Application for MDMA is happening now. How do clinicians feel about this potential treatment for PTSD?
Brain Capital: a fresh approach to technologies and investing.
What are ghosts and ghouls compared to the looming threat of the declining global biological state?
What is the clinician’s role in reversing stigma for better outcomes?
To expertly utilize polypharmacy, it is imperative that clinicians stay abreast of new literature, check for drug-drug interactions, and be aware of emerging trends in drug use.
How important is it to understand a person’s ethnicity and cultural norms when developing a treatment plan?
Explore the relationship between cannabis use and psychosis.
Bipolar I disorder (BD-I) can be difficult to diagnose and treat due to overlapping symptoms and stigma. What can clinicians utilize to help manage BD-I for better long-term outcomes?
Financial success requires planning and thoughtfulness. What do female physicians wish they would have done differently or better?
This show is an example of how performances can be used to improve public mental health through inclusive and authentic positive representation, and inspiring hope.
Panelists discuss how viloxazine fits into both pediatric and adult ADHD treatment plans, especially as a non-stimulant option for patients with complex cases or concerns about stimulant side effects, while emphasizing flexible dosing and caregiver involvement.
If you missed this session, check out the highlights here!
An organizational psychiatrist discusses the psychology of fraud—and the unique role of psychiatry in helping us better understand it.
Explore best practices in child mental health through real case studies in the DSM-5-TR Casebook and Treatment Guide for Child Mental Health, featuring expert insights and treatment strategies.
What kind of person comes to mind when you think of eating disorders? Here’s why you might be wrong.
How do we address the growing crisis of health care worker mental health?
In this CME, learn to recognize risk factors and potential identifiers of human trafficking and identify trauma-informed approaches in evaluating human trafficking victims and survivors.
The high co-occurrence of chronic pain and PTSD and their possible entanglement underline the importance of conducting assessment for both conditions.
How can you provide comprehensive care in underserved environments, particularly for individuals with complex mental health needs? Amitha Dhingra, MD, weighs in.
How should clinicians approach treatment when their patient disagrees with the diagnosis?
The authors make the case for national education mandates from accreditation organizations and congressional support to require enhanced education of all clinicians who care for older adults.
Mask-wearing can help protect individuals from COVID-19 infection—but it also has several other unexpected advantages.